111 related articles for article (PubMed ID: 1319083)
1. Differential influence of prognostic factors on the occurrence of metastases at various anatomical sites in human breast cancer.
Zedeler K; Keiding N; Kamby C
Stat Med; 1992 Feb; 11(3):281-94. PubMed ID: 1319083
[TBL] [Abstract][Full Text] [Related]
2. [The significance of prognostic factors on the occurrence of metastases from breast cancer to various localizations].
Zedeler K; Keiding N; Kamby C
Ugeskr Laeger; 1994 Jan; 156(1):42-7. PubMed ID: 8291155
[TBL] [Abstract][Full Text] [Related]
3. The effect of distant metastases sites on survival in de novo stage-IV breast cancer: A SEER database analysis.
Wu SG; Li H; Tang LY; Sun JY; Zhang WW; Li FY; Chen YX; He ZY
Tumour Biol; 2017 Jun; 39(6):1010428317705082. PubMed ID: 28653887
[TBL] [Abstract][Full Text] [Related]
4. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
5. Primary breast cancer phenotypes associated with propensity for central nervous system metastases.
Tham YL; Sexton K; Kramer R; Hilsenbeck S; Elledge R
Cancer; 2006 Aug; 107(4):696-704. PubMed ID: 16826579
[TBL] [Abstract][Full Text] [Related]
6. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Tvedskov TF
Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
[TBL] [Abstract][Full Text] [Related]
7. The impact of method of biopsy on the incidence of breast cancer sentinel lymph node metastases.
Meattini I; Giannotti E; Abdulcadir D; Saieva C; Guerrieri AM; Vanzi E; Scartoni D; Cecchini S; Sanchez LJ; Orzalesi L; Casella D; Bianchi S; Livi L; Nori J
Eur J Surg Oncol; 2014 Mar; 40(3):277-81. PubMed ID: 24388742
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer.
Diessner J; Wischnewsky M; Stüber T; Stein R; Krockenberger M; Häusler S; Janni W; Kreienberg R; Blettner M; Schwentner L; Wöckel A; Bartmann C
BMC Cancer; 2016 May; 16():307. PubMed ID: 27175930
[TBL] [Abstract][Full Text] [Related]
9. Incidence and patterns of distant metastases for patients with early-stage breast cancer after breast conservation treatment.
Berman AT; Thukral AD; Hwang WT; Solin LJ; Vapiwala N
Clin Breast Cancer; 2013 Apr; 13(2):88-94. PubMed ID: 23218473
[TBL] [Abstract][Full Text] [Related]
10. Risk factors related to late metastases in 1,372 melanoma patients disease free more than 10 years.
Osella-Abate S; Ribero S; Sanlorenzo M; Maule MM; Richiardi L; Merletti F; Tomasini C; Marra E; Macripò G; Fierro MT; Quaglino P
Int J Cancer; 2015 May; 136(10):2453-7. PubMed ID: 25331444
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer recurrence, bone metastases, and visceral metastases in women with stage II and III breast cancer in Denmark.
Cronin-Fenton D; Kjærsgaard A; Nørgaard M; Amelio J; Liede A; Hernandez RK; Sørensen HT
Breast Cancer Res Treat; 2018 Jan; 167(2):517-528. PubMed ID: 28948396
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and patho-anatomic aspects of metastases of breast cancer].
Heberling D; Höffken H; Kühn W; Leppien G; Rieth J; Rummel HH; Tshahagane C
Geburtshilfe Frauenheilkd; 1984 Feb; 44(2):79-83. PubMed ID: 6329894
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of modalities for recurrent breast cancer patients].
Tohnosu N; Onoda S; Okuyama K; Koide Y; Awano T; Kinoshita H; Matsubara H; Sano T; Nakaichi H; Isono K
Nihon Gan Chiryo Gakkai Shi; 1990 Dec; 25(12):2744-51. PubMed ID: 2074383
[TBL] [Abstract][Full Text] [Related]
14. Sites of distant metastases and overall survival in ovarian cancer: A study of 1481 patients.
Deng K; Yang C; Tan Q; Song W; Lu M; Zhao W; Lou G; Li Z; Li K; Hou Y
Gynecol Oncol; 2018 Sep; 150(3):460-465. PubMed ID: 30001833
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of the number of bone scan abnormalities at the time of initial bone metastatic recurrence in breast carcinoma.
Jacobson AF; Shapiro CL; Van den Abbeele AD; Kaplan WD
Cancer; 2001 Jan; 91(1):17-24. PubMed ID: 11148555
[TBL] [Abstract][Full Text] [Related]
16. Semiparametric Marshall-Olkin models applied to the occurrence of metastases at multiple sites after breast cancer.
Klein JP; Keiding N; Kamby C
Biometrics; 1989 Dec; 45(4):1073-86. PubMed ID: 2611318
[TBL] [Abstract][Full Text] [Related]
17. Optimal surveillance for postoperative metastasis in breast cancer patients.
Makita M; Sakai T; Ogiya A; Kitagawa D; Morizono H; Miyagi Y; Iijima K; Iwase T
Breast Cancer; 2016 Mar; 23(2):286-94. PubMed ID: 25294313
[TBL] [Abstract][Full Text] [Related]
18. De novo metastasis in breast cancer: occurrence and overall survival stratified by molecular subtype.
Press DJ; Miller ME; Liederbach E; Yao K; Huo D
Clin Exp Metastasis; 2017 Dec; 34(8):457-465. PubMed ID: 29288366
[TBL] [Abstract][Full Text] [Related]
19. Treatment strategies in recurrent esophageal or junctional cancer.
Butter R; Lagarde SM; van Oijen MGH; Anderegg MCJ; Gisbertz SS; Meijer SL; Hulshof MCCM; Bergman JJGHM; van Berge Henegouwen MI; van Laarhoven HWM
Dis Esophagus; 2017 Sep; 30(9):1-9. PubMed ID: 28859371
[TBL] [Abstract][Full Text] [Related]
20. Incidence of bone metastases and survival after a diagnosis of bone metastases in breast cancer patients.
Harries M; Taylor A; Holmberg L; Agbaje O; Garmo H; Kabilan S; Purushotham A
Cancer Epidemiol; 2014 Aug; 38(4):427-34. PubMed ID: 24923857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
